Psychopharmacology and Psychiatry Updates

We review the BAART trial on risperidone vs aripiprazole in irritability associated with autism spectrum disorder.

We discuss studies on the safety of antidepressants in pregnancy regarding autism risk, IQ, cardiac malformations, miscarriage, and neonatal mortality.

We discuss a study that investigates the relationship between prenatal stress and a diagnosis of borderline personality disorder in offspring.

We explore the case of Rosa, a 36 year old pregnant woman with a history of depression, we discuss how to adjust pharmacotherapy, psychotherapy and other factors to keep in mind.

In this podcast episode with Dr. Jim Phelps, we review the evidence for several agents used to help patients with depression and cognitive dysfunction symptoms. We speak about modafinil, vortioxetine, duloxetine and amphetamines.

In this podcast episode, we delve into the neuroprotective role of lithium in preventing dementia. We review a 2019 randomized controlled trial that administered low-dose lithium to patients with mild cognitive impairment.

In this podcast episode, we review the major FDA approvals in psychopharmacology for 2019. We explore brexanolone, bremelanotide, the asenapine skin patch, esketamine, cariprazine, and lumateperone.

In this podcast episode, we discuss a case of a 65-year-old patient with first-episode MDD that is treatment resistant. With the expertise of Dr. Ken Gillman, we unpack how to manage this case with an MAOI.

In this podcast episode, we discuss a 2019 study that addresses the question of whether antidepressants increase dementia risk and the possible underlying mechanisms.

In this podcast episode, you get to meet some of the humans of Psychopharmacology Institute. We discuss what we enjoy, what we have to offer and how you can join our team.

In this podcast episode, Dr. Jim Phelps shares the findings of a tantalizing study that found that agents like allopurinol, angiotensin agents, aspirin and non-steroidals may be effective for the treatment of depression.

This episode is the starter pack for the use of monoamine oxidase inhibitors in psychiatry practice. We learn the mechanism of action, food-related instructions and MAOI drug interactions.

In this podcast episode, Dr. Jim Phelps reviews a meta-analysis about ketamine for suicidal ideation and how effective it is.

In this podcast episode we learn the core concepts surrounding ketamine and esketamine; a very hot topic in psychiatry today. We have Dr. Sam Wilkinson and Dr. Joseph Goldberg joining us.

In this podcast episode, we dig further into the practical use of pharmacogenetic testing in psychiatric practice. We address its limitations and the resources you can use to guide your decision making.